You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
譜尼測試(300887.SZ):子公司內蒙古譜尼醫學檢驗實驗室獲批開展臨牀細胞分子遺傳學臨牀基因擴增檢驗
格隆匯 01-11 16:08

格隆匯1月11日丨譜尼測試(300887.SZ)公佈,近日,譜尼測試集團股份有限公司(“譜尼集團”)下屬全資子公司內蒙古譜尼醫學檢驗實驗室(“內蒙古譜尼醫學”)接到內蒙古自治區臨牀檢驗中心的通知:經評審專家委員會專家評審,認定內蒙古譜尼醫學檢驗實驗室臨牀基因擴增檢驗實驗室符合相關技術要求,可以開展臨牀細胞分子遺傳學專業中臨牀基因擴增檢驗業務。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account